Inventor · disambiguated record
Katelyn M. Willis
Also filed as: WILLIS KATELYN · WILLIS KATELYN M · WILLIS KATELYN MCKABE
12 granted patents·12 pending applications·15 citations·filing 2016–2025
85Inventor score
Top patents by PatentIndex Score
24 records- 0192US11866507B2Multispecific polypeptide constructs having constrained CD3 binding and methods of using the sameINHIBRX INC·Filed 2018·Granted Jan 9, 2024·8 cites·10 claims
- 0286US12331126B2OX40-binding polypeptides and uses thereofINHIBRX BIOSCIENCES INC·Filed 2024·Granted Jun 17, 2025·0 cites·47 claims
- 0384US10093742B2Multispecific GITR-binding fusion proteins and methods of use thereofINHIBRX INC·Filed 2016·Granted Oct 9, 2018·4 cites·57 claims
- 0483US10308720B2Multivalent and multispecific DR5-binding fusion proteinsINHIBRX INC·Filed 2016·Granted Jun 4, 2019·3 cites·24 claims
- 0583US2024376220A1Multivalent and Multispecific DR5-Binding Fusion ProteinsINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0679US12331132B2Multispecific polypeptide constructs having constrained CD3 binding and related methods and usesINHIBRX BIOSCIENCES INC·Filed 2023·Granted Jun 17, 2025·0 cites·21 claims
- 0778US12012459B2OX40-binding polypeptides and uses thereofINHIBRX INC·Filed 2022·Granted Jun 18, 2024·0 cites·39 claims
- 0876US11976126B2Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cellsINHIBRX INC·Filed 2021·Granted May 7, 2024·0 cites·24 claims
- 0975US2025092137A1Multispecific polypeptide constructs containing a constrained cd3 binding domain and a receptor binding region and methods of using the sameINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1074US2025361319A1Multispecific polypeptide constructs having constrained cd3 binding and related methods and usesINHIBRX BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1173US2024101704A1Multispecific polypeptide constructs having constrained cd3 binding and methods of using the sameINHIBRX INC·Filed 2023·Application pending·0 cites
- 1270US11447556B2OX40-binding polypeptides and uses thereofINHIBRX INC·Filed 2019·Granted Sep 20, 2022·0 cites·60 claims
- 1370US11117973B2Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasmsINHIBRX INC·Filed 2019·Granted Sep 14, 2021·0 cites·39 claims
- 1463US10844129B2Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acidsINHIBRX INC·Filed 2018·Granted Nov 24, 2020·0 cites·34 claims
- 1563US2025313623A1Dll3 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1661US12365728B2DLL3 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2019·Granted Jul 22, 2025·0 cites·32 claims
- 1761US2025302948A1DR5 Agonist and IAP Antagonist Combination TherapyINHIBRX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1861US2019330366A1Multispecific polypeptide constructs having constrained cd3 binding and related methods and usesINHIBRX INC·Filed 2019·Application pending·0 cites
- 1961US2025215101A1DR5 Agonist and PLK1 Inhibitor or CDK Inhibitor Combination TherapyINHIBRX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2059US12195533B2Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the sameINHIBRX BIOSCIENCES INC·Filed 2019·Granted Jan 14, 2025·0 cites·27 claims
- 2155US2023235005A1Polypeptides Comprising Modified IL-2 Polypeptides and Uses ThereofINHIBRX INC·Filed 2021·Application pending·0 cites
- 2251US2017320958A1Multivalent and multispecific gitr-binding fusion proteinsINHIBRX LP·Filed 2017·Application pending·0 cites
- 2349US2022089667A1Polypeptides Comprising Modified IL-2 Polypeptides and Uses ThereofINHIBRX INC·Filed 2020·Application pending·0 cites
- 2441US2023124851A1B7h3 single domain antibodies and therapeutic compositions thereofINHIBRX LNC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katelyn M. Willis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →